Andrea
Pucci

Mid-Level Associate
The future belongs to those who believe in the beauty of their dreams Eleanor Roosevelt

Andrea focuses on corporate law, with particular emphasis on M&A, private equity and venture capital transactions.

He has developed significant experience in the life sciences, healthcare, technology and regulated industries, advising investment funds, industrial players and start-ups on extraordinary transactions, acquisitions, disposals and investments.

Andrea joined LCA in January 2026, where he works within the Corporate M&A Department, assisting Italian and international clients in the negotiation and completion of acquisition and investment transactions, as well as in the management of legal due diligence activities, with particular focus on the life sciences and technology sectors.

He previously gained professional experience at leading international law firms and in Brussels at Medicines for Europe and the European Generic and Biosimilar Association (EGA), where he provided legal and regulatory advice at European level.

Commercial and corporate M&A – Private Equity Start Up & Venture Capital

You might also be interested in

09.10.2026
LCA advises the selling shareholders on the sale of Planta to SIS

The transaction strengthens the maize genetics platform of the BF group’s seed division

05.10.2026
LCA alongside Impresoft in the acquisition of Marketplace Generation and Addiction ...

The group controlled by Clessidra Private Equity strengthens its e-commerce and MarTech offering  

01.10.2026
LCA Studio Legale strengthens the Corporate M&A practice with the arrival of ...

The firm consolidates the practice in extraordinary transactions and in advising Italian and U.S. investors  

25.09.2026
LCA advises the sellers on the sale of 60% of Ecupharma to Adamed Group

Majority stake sold in the Italian pharmaceutical company active in neurology, psychiatry, urology and diabetology

21.09.2026